12 Jan 2017 --- Glatt Ingenieurtechnik GmbH has doubled the number of employees in its Dresden branch in just one year. After a successful first year, the Dresden subsidiary of the engineering expert Glatt Ingenieurtechnik is planning further hires for 2017. The engineers operate in a specialist segment, which only master few: the engineering of plants for the production of pharmaceutical and biotechnological active substances – including turnkey factories – for vaccines, anti-cancer drugs, anti-diabetes medicine, and processing of blood plasma into therapeutics.
